Stock Research for KMDA

KMDA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

KMDA Stock Chart & Research Data

The KMDA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the KMDA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


KMDA Due diligence Resources & Stock Charts

The KMDA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View KMDA Detailed Price Forecast - CNN Money CNN View KMDA Detailed Summary - Google Finance
Yahoo View KMDA Detailed Summary - Yahoo! Finance Zacks View KMDA Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View KMDA Trends & Analysis - Trade-Ideas Barrons View KMDA Major Holders - Barrons
NASDAQ View KMDA Call Transcripts - NASDAQ Seeking View KMDA Breaking News & Analysis - Seeking Alpha
Spotlight View KMDA Annual Report - CompanySpotlight.com OTC Report View KMDA OTC Short Report - OTCShortReport.com
TradeKing View KMDA Fundamentals - TradeKing Charts View KMDA SEC Filings - Bar Chart
WSJ View Historical Prices for KMDA - The WSJ Morningstar View Performance/Total Return for KMDA - Morningstar
MarketWatch View the Analyst Estimates for KMDA - MarketWatch CNBC View the Earnings History for KMDA - CNBC
StockMarketWatch View the KMDA Earnings - StockMarketWatch MacroAxis View KMDA Buy or Sell Recommendations - MacroAxis
Bullish View the KMDA Bullish Patterns - American Bulls Short Pains View KMDA Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View KMDA Stock Mentions - StockTwits PennyStocks View KMDA Stock Mentions - PennyStockTweets
Twitter View KMDA Stock Mentions - Twitter Invest Hub View KMDA Investment Forum News - Investor Hub
Yahoo View KMDA Stock Mentions - Yahoo! Message Board Seeking Alpha View KMDA Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for KMDA - SECform4.com Insider Cow View Insider Transactions for KMDA - Insider Cow
CNBC View KMDA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for KMDA - OTC Markets
Yahoo View Insider Transactions for KMDA - Yahoo! Finance NASDAQ View Institutional Holdings for KMDA - NASDAQ


Stock Charts

FinViz View KMDA Stock Insight & Charts - FinViz.com StockCharts View KMDA Investment Charts - StockCharts.com
BarChart View KMDA Stock Overview & Charts - BarChart Trading View View KMDA User Generated Charts - Trading View


Latest Financial News for KMDA

5 Biotech Stocks Under $10 Worthy of Investors' Attention
Posted on Friday June 15, 2018

Small biotech stocks are good bets with lower market cap as well as share price.


Results of Kamada’s Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association’s 78th Scientific Sessions
Posted on Monday June 04, 2018

“We are excited to present the data from our Phase 2 trial of AAT in newly diagnosed T1D patients at such a prestigious medical conference,” said Amir London, Kamada’s Chief Executive Officer.  “Based on the results generated to date, and feedback received from the medical community, we believe that further studies in a larger population are warranted.


Biotech and energy top list for best paying jobs
Posted on Friday May 25, 2018

Engineers in both the energy and biotech sectors are among top earners, surpassing Wall Street. Yahoo Finance's Seana Smith, Jennifer Rogers and Pras Subramanian discuss.


Kamada: 1Q Earnings Snapshot
Posted on Tuesday May 15, 2018

On a per-share basis, the Ness Ziona, Israel-based company said it had profit of 3 cents. The biopharmaceutical posted revenue of $17.4 million in the period. Kamada expects full-year revenue in the range ...


Enter a stock symbol to view the stock details.